Company news
Atricure, Inc. (NASDAQ:ATRC) news
Atricure, Inc. news releases on 6ix. Latest, Jul 7, 2021: AtriCure to Announce Second Quarter 2021 Financial Results
Press releases — page 3
AtriCure to Announce Second Quarter 2021 Financial Results
July 6, 2021
AtriCure Names Two New Members to the Board of Directors
June 14, 2021
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
April 28, 2021
AtriCure Reports First Quarter 2021 Financial Results
April 26, 2021
AtriCure Names B. Kristine Johnson Board Chair
April 7, 2021
AtriCure to Announce First Quarter 2021 Financial Results
April 5, 2021
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference
March 1, 2021
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
February 22, 2021
AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference
February 9, 2021
AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
February 1, 2021
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
January 10, 2021
AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy
January 3, 2021
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
December 13, 2020
AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
November 18, 2020
AtriCure Reports Third Quarter 2020 Financial Results
November 4, 2020
AtriCure to Announce Third Quarter 2020 Financial Results
October 12, 2020
AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference
August 31, 2020
AtriCure Announces Angie Wirick as Chief Financial Officer
August 5, 2020
AtriCure Reports Second Quarter 2020 Financial Results
July 27, 2020
AtriCure to Announce Second Quarter 2020 Financial Results
July 6, 2020
AtriCure Announces Proposed Public Offering of Common Stock
May 10, 2020
AtriCure Announces Pricing of Public Offering of Common Stock
May 10, 2020
AtriCure Announces Results from CONVERGE IDE Clinical Trial
May 7, 2020
AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society (HRS) Virtual Meeting
April 29, 2020
AtriCure Reports First Quarter 2020 Financial Results
April 28, 2020
AtriCure to Announce First Quarter 2020 Financial Results
April 14, 2020
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
April 12, 2020
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
April 8, 2020
AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results
February 17, 2020
AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference
February 2, 2020
AtriCure to Announce Fourth Quarter and Full Year 2019 Financial Results
January 27, 2020
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019, Provides Financial Outlook for 2020
January 12, 2020
AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol
January 6, 2020
AtriCure to Participate at the 38th Annual JP Morgan Healthcare Conference
December 15, 2019
AtriCure Names Two Industry Veterans to Board of Directors
December 3, 2019
AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference
November 11, 2019
AtriCure Reports Third Quarter 2019 Financial Results
October 29, 2019
AtriCure to Announce Third Quarter 2019 Financial Results
October 7, 2019